Cancer BiologybioRxivPreprint
TAO Kinase 3 Overexpression Is a Poor Prognosis Marker for Lung Adenocarcinoma and Predicts Paclitaxel Resistance
Tsung-Ching Lai, Yi-Chieh Yang, Yu-Chan Chang…·Michael Hsiao
This study shows TAOK3 overexpression correlates with poor prognosis and paclitaxel resistance in lung adenocarcinoma, suggesting it as a therapeutic target.
DOI 10.1101/622621